These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37591312)

  • 1. Epidemiologic and microbiologic evaluation of catheter-line bloodstream infection in a pediatric hematopoietic stem cell transplant center.
    Aksoy BA; Kara M; Sütçü M; Özbek A; Ersoy GZ; Öner ÖB; Aydoğdu S; Gül D; Bozkurt C; Fışgın T
    Am J Infect Control; 2024 Jan; 52(1):81-86. PubMed ID: 37591312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of a Best Practice Prevention Bundle on Central Line-associated Bloodstream Infection (CLABSI) Rates and Outcomes in Pediatric Hematology, Oncology, and Hematopoietic Cell Transplantation Patients in Inpatient and Ambulatory Settings.
    Ardura MI; Bibart MJ; Mayer LC; Guinipero T; Stanek J; Olshefski RS; Auletta JJ
    J Pediatr Hematol Oncol; 2021 Jan; 43(1):e64-e72. PubMed ID: 32960848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining Incidence and Risk Factors for Catheter-Associated Bloodstream Infections in an Outpatient Adult Hematopoietic Cell Transplantation Program.
    McDonald MK; Culos KA; Gatwood KS; Prow C; Chen H; Savani BN; Byrne M; Kassim AA; Engelhardt BG; Jagasia M; Satyanarayana G
    Biol Blood Marrow Transplant; 2018 Oct; 24(10):2081-2087. PubMed ID: 29753159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of central line bundles on the timing of catheter-associated bloodstream infections and their microbiological distribution in critically ill children.
    Devrim İ; Sandal OS; Çelebi MY; Hepduman P; Gönüllü A; Atakul G; Kara AA; Oruç Y; Gülfidan G; Bayram N; Ağın H
    Eur J Pediatr; 2023 Oct; 182(10):4625-4632. PubMed ID: 37555974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventive strategies for central line-associated bloodstream infections in pediatric hematopoietic stem cell transplant recipients.
    Barrell C; Covington L; Bhatia M; Robison J; Patel S; Jacobson JS; Buet A; Graham PL; Saiman L
    Am J Infect Control; 2012 Jun; 40(5):434-9. PubMed ID: 21907455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moving CLABSI prevention beyond the intensive care unit: risk factors in pediatric oncology patients.
    Kelly M; Conway M; Wirth K; Potter-Bynoe G; Billett AL; Sandora TJ
    Infect Control Hosp Epidemiol; 2011 Nov; 32(11):1079-85. PubMed ID: 22011534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bloodstream and central line isolates from hematopoietic stem cell transplant recipients: data from a developing country.
    Ali N; Adil SN; Shaikh MU
    Transpl Infect Dis; 2014 Feb; 16(1):98-105. PubMed ID: 24383473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterial bloodstream infections in pediatric allogeneic hematopoietic stem cell recipients before and after implementation of a central line-associated bloodstream infection protocol: A single-center experience.
    Chang AK; Foca MD; Jin Z; Vasudev R; Laird M; Schwartz S; Qureshi M; Kolb M; Levinson A; Bhatia M; Kung A; Garvin J; George D; Della-Latta P; Whittier S; Saiman L; Satwani P
    Am J Infect Control; 2016 Dec; 44(12):1650-1655. PubMed ID: 27378008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central line-associated bloodstream infection in childhood malignancy: Single-center experience.
    Miliaraki M; Katzilakis N; Chranioti I; Stratigaki M; Koutsaki M; Psarrou M; Athanasopoulos E; Stiakaki E
    Pediatr Int; 2017 Jul; 59(7):769-775. PubMed ID: 28376269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for central line-associated bloodstream infection in pediatric oncology patients with a totally implantable venous access port: A cohort study.
    Viana Taveira MR; Lima LS; de Araújo CC; de Mello MJ
    Pediatr Blood Cancer; 2017 Feb; 64(2):336-342. PubMed ID: 27666952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central venous catheter-associated bloodstream infections in a pediatric intensive care unit: effect of the location of catheter insertion.
    Krishnaiah A; Soothill J; Wade A; Mok QQ; Ramnarayan P
    Pediatr Crit Care Med; 2012 May; 13(3):e176-80. PubMed ID: 22561276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lower risk of bloodstream infections for peripherally inserted central catheters compared to central venous catheters in critically ill patients.
    Pitiriga V; Bakalis J; Theodoridou K; Kanellopoulos P; Saroglou G; Tsakris A
    Antimicrob Resist Infect Control; 2022 Nov; 11(1):137. PubMed ID: 36352414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for central line-associated bloodstream infection in pediatric intensive care units.
    Wylie MC; Graham DA; Potter-Bynoe G; Kleinman ME; Randolph AG; Costello JM; Sandora TJ
    Infect Control Hosp Epidemiol; 2010 Oct; 31(10):1049-56. PubMed ID: 20731595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asymptomatic central line-associated bloodstream infections in children implanted with long term indwelling central venous catheters in a teaching hospital, Sri Lanka.
    Jayaweera JAAS; Sivakumar D
    BMC Infect Dis; 2020 Jun; 20(1):457. PubMed ID: 32600427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors predicting the cause and prognosis of central line-associated bloodstream infections.
    Nemoto T; Kunishima H; Shimizu G; Hirose M; Yamasaki Y; Nishisako H; Takagi T; Matsuda T
    J Infect Chemother; 2015 Feb; 21(2):118-22. PubMed ID: 25483264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in Central Line-Associated Bloodstream Infection Rates Among Children With Immune Compromised Conditions: An 11-Year Review.
    Linder LA; Gerdy C; Jo Y; Wilson A
    J Pediatr Oncol Nurs; 2018; 35(6):382-391. PubMed ID: 29665727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duration of central venous catheter placement and central line-associated bloodstream infections after the adoption of prevention bundles: a two-year retrospective study.
    Pitiriga V; Bakalis J; Kampos E; Kanellopoulos P; Saroglou G; Tsakris A
    Antimicrob Resist Infect Control; 2022 Jul; 11(1):96. PubMed ID: 35841083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for vascular catheter-related bloodstream infections in pediatric intensive care units.
    Torre FPF; Baldanzi G; Troster EJ
    Rev Bras Ter Intensiva; 2018; 30(4):436-442. PubMed ID: 30672969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central venous catheter-associated bloodstream infections in pediatric hematology-oncology patients and effectiveness of antimicrobial lock therapy.
    Tsai HC; Huang LM; Chang LY; Lee PI; Chen JM; Shao PL; Hsueh PR; Sheng WH; Chang YC; Lu CY
    J Microbiol Immunol Infect; 2015 Dec; 48(6):639-46. PubMed ID: 25311403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Healthcare Burden, Risk Factors, and Outcomes of Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections after Stem Cell Transplantation.
    Dandoy CE; Haslam D; Lane A; Jodele S; Demmel K; El-Bietar J; Flesch L; Myers KC; Pate A; Rotz S; Daniels P; Wallace G; Nelson A; Waters H; Connelly B; Davies SM
    Biol Blood Marrow Transplant; 2016 Sep; 22(9):1671-1677. PubMed ID: 27311966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.